The UK’s new Data (Use and Access) Bill is set to mark quite a shift in the country’s data laws. Introduced in the House of Lords in October 2024, the Bill aims to advance prior regulatory Bills such as the Data Protection and Digital Information (DPDI) Bill. As it progresses through Parliament, we look [...]
Upholding patient privacy is crucial throughout the clinical trial process, however, organisations must continue to maintain these safeguards even after the trial concludes. In the final blog of our three-part series, we look at how DPOs support Sponsors and Contract Research Organisation (CROs) in safeguarding personal data as a clinical trial comes to an [...]
Brazil’s National Data Protection Authority (ANPD) has initiated a public consultation to shape future AI and automated decision-making regulations, aligning these frameworks with Brazil’s General Data Protection Law (LGPD). This marks a proactive move to ensure that AI-driven processes adhere to data protection principles, while balancing technological growth with the rights of data subjects. [...]
November is one of the busiest months for ecommerce online traffic, starting with China’s Singles Day (known as 11:11 in other regions); the biggest retail event worldwide since it first began in 1993. November also means Thanksgiving and Black Friday, followed swiftly by Cyber Monday, with retailers amplifying their marketing online and in stores. This means [...]
On 9th October 2024, the Australian Government tabled the Cyber Security Bill 2024 (the Bill) in the Federal Parliament. While the Security of Critical Infrastructure Act 2018 already imposes cybersecurity obligations on owners and operators of critical infrastructure, the Bill is the first Australian law specifically designed to strengthen cybersecurity in the public and [...]
Clinical trials can be complex and layered machines that require multiple spheres of compliance to be accounted for. Our previous blog covered embedding privacy by design, consent, and strategies for mitigating data protection risks at the outset of a clinical trial. In this piece, we look at the main challenges data protection officers (DPOs) [...]
Now that the EU AI Act has entered into force, an increasing need for integrating Environmental, Social, and Governance (ESG) principles into AI frameworks is becoming more evident. These principles can be foundations for building greater public trust in AI system use as they provide a framework for greater transparency and corporate social responsibility. [...]
As data protection regulations and technology continue to evolve, there is a much greater need for strong corporate governance frameworks to improve accountability. For some organisations, there is a requirement to appoint a data protection officer (DPO), either as a member of the extended legal counsel team internally or by working with an externally [...]
Earlier this month, HewardMills participated in the inaugural B Corp Festival in Oxford, a two-day event assembling the largest gathering of B Corps to date. With a theme of ‘Louder than Words’, it was a great opportunity to connect with businesses from numerous sectors, all driven by a common purpose to actively create a [...]
When starting a clinical trial, safeguarding patient privacy is one of many aspects of regulatory compliance to implement from the outset. With many other considerations to take care of, working closely with a Data Protection Officer (DPO) can make the job of complying with key privacy regulations a lot easier. In this three-part series, [...]
HewardMills Ltd is a company registered in England and Wales | Registered office: 77 Farringdon Road, London EC1M 3JU | Registration number: 11211970 | All rights reserved | © Copyright 2020 – 2024 | Privacy notice
